These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 32278658

  • 1. Impact of successful pediatric ureteropelvic junction obstruction surgery on urinary HIP/PAP and BD-1 levels.
    Gupta S, Nicassio L, Junquera GY, Jackson AR, Fuchs M, McLeod D, Alpert S, Jayanthi VR, DaJusta D, McHugh KM, Becknell B, Ching CB.
    J Pediatr Urol; 2020 Oct; 16(5):592.e1-592.e7. PubMed ID: 32278658
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty.
    Cost NG, Noh PH, Devarajan P, Ivancic V, Reddy PP, Minevich E, Bennett M, Haffner C, Schulte M, DeFoor WR.
    J Urol; 2013 Oct; 190(4 Suppl):1462-7. PubMed ID: 23791906
    [Abstract] [Full Text] [Related]

  • 4. Reoperative robotic pyeloplasty in children.
    Davis TD, Burns AS, Corbett ST, Peters CA.
    J Pediatr Urol; 2016 Dec; 12(6):394.e1-394.e7. PubMed ID: 27423387
    [Abstract] [Full Text] [Related]

  • 5. Differentiating Asymptomatic Bacteriuria From Urinary Tract Infection in the Pediatric Neurogenic Bladder Population: NGAL As a Promising Biomarker.
    Gupta S, Preece J, Haynes A, Becknell B, Ching C.
    Top Spinal Cord Inj Rehabil; 2019 Dec; 25(3):214-221. PubMed ID: 31548788
    [Abstract] [Full Text] [Related]

  • 6. Elevated urinary lipocalin-2, interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction.
    Yu L, Zhou L, Li Q, Li S, Luo X, Zhang C, Wu B, Brooks JD, Sun H.
    J Pediatr Urol; 2019 Feb; 15(1):44.e1-44.e7. PubMed ID: 30420258
    [Abstract] [Full Text] [Related]

  • 7. Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study.
    Gerber C, Harel M, Lynch ML, Herbst KW, Ferrer FA, Shapiro LH.
    J Pediatr Urol; 2016 Apr; 12(2):120.e1-7. PubMed ID: 26705690
    [Abstract] [Full Text] [Related]

  • 8. Hydronephrosis: Comparison of extrinsic vessel versus intrinsic ureteropelvic junction obstruction groups and a plea against the vascular hitch procedure.
    Menon P, Rao KL, Sodhi KS, Bhattacharya A, Saxena AK, Mittal BR.
    J Pediatr Urol; 2015 Apr; 11(2):80.e1-6. PubMed ID: 25794866
    [Abstract] [Full Text] [Related]

  • 9. Urinary biomarkers in hydronephrosis.
    Madsen MG.
    Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
    [Abstract] [Full Text] [Related]

  • 10. Laparoscopic pyeloplasty versus open pyeloplasty for recurrent ureteropelvic junction obstruction in children.
    Abdel-Karim AM, Fahmy A, Moussa A, Rashad H, Elbadry M, Badawy H, Hammady A.
    J Pediatr Urol; 2016 Dec; 12(6):401.e1-401.e6. PubMed ID: 27614698
    [Abstract] [Full Text] [Related]

  • 11. Urinary carbohydrate antigen 19-9/creatinine ratio: A non-invasive marker for follow-up of unilateral ureteropelvic junction obstruction in children.
    Alizadeh F, Taefnia AM, Haghdani S.
    J Pediatr Urol; 2018 Feb; 14(1):62.e1-62.e4. PubMed ID: 29079483
    [Abstract] [Full Text] [Related]

  • 12. Changes in differential renal function after pyeloplasty in infants and children.
    Nordenström J, Koutozi G, Holmdahl G, Abrahamsson K, Sixt R, Sjöström S.
    J Pediatr Urol; 2020 Jun; 16(3):329.e1-329.e8. PubMed ID: 32146062
    [Abstract] [Full Text] [Related]

  • 13. The role of voiding cystourethrography in asymptomatic unilateral isolated ureteropelvic junction obstruction: A retrospective study.
    ElSheemy MS, Ghoneima W, Abdelwahhab M, Aboulela W, Daw K, Shouman AM, Shoukry AI, El Ghoneimy M, Morsi HA, Badawy H.
    J Pediatr Urol; 2017 Apr; 13(2):206.e1-206.e7. PubMed ID: 27964829
    [Abstract] [Full Text] [Related]

  • 14. The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants.
    Pavlaki A, Printza N, Farmaki E, Stabouli S, Taparkou A, Sterpi M, Dotis J, Papachristou F.
    Pediatr Nephrol; 2020 Jan; 35(1):163-170. PubMed ID: 31606750
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association between urinary biomarkers MMP-7/TIMP-2 and reduced renal function in children with ureteropelvic junction obstruction.
    Wang HS, Cho PS, Zhi H, Kostel SA, DiMartino S, Dagher AM, Davis KH, Cabour LD, Shimmel A, Lee J, Froehlich JW, Zurakowski D, Moses MA, Lee RS.
    PLoS One; 2022 Jan; 17(7):e0270018. PubMed ID: 35834547
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Can urinary caspase-3 and cytochrome c levels be used as predictive biomarkers in the management of unilateral antenatal hydronephrosis?
    Zeybek SG, Selvi İ, Oktar T, Dönmez Mİ, Ziylan O, Seçkin Ş, Küçükgergin C.
    Int Urol Nephrol; 2024 Aug; 56(8):2459-2466. PubMed ID: 38494584
    [Abstract] [Full Text] [Related]

  • 19. Urinary polyomavirus: novel biomarker of congenital ureteropelvic junction obstruction.
    Assadi F, Mazaheri M.
    J Pediatr Urol; 2020 Feb; 16(1):107.e1-107.e5. PubMed ID: 31818677
    [Abstract] [Full Text] [Related]

  • 20. Incidence of pathologic postobstructive diuresis after resolution of ureteropelvic junction obstruction with a normal contralateral kidney.
    Roth JD, Lesier JD, Casey JT, Szymanski KM, Whittam BM, Misseri R, Rink RC, Cain MP.
    J Pediatr Urol; 2018 Dec; 14(6):557.e1-557.e6. PubMed ID: 30139574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.